REFERENCES
- Vile R.G., Sunassee K., Diaz R.M. Strategies for Achieving Multiple Layers of Selectivity in Gene Therapy. Molecular Medicine Today 1998; 4: 84–92
- Fischer D., Bieber T., Li Y., Elsässer H.-P., Kissel T. A Novel Non-Viral Vector for DNA Delivery Based on Low Molecular Weight, Branched Polyethylenimine: Effect of Molecular Weight on Transfection Efficiency and Cytotoxicity. Pharmaceutical research 1999; 16: 1273–1279
- Sternberg B., Sorgi F.L., Huang L. New Structures in Complex Formation Between DNA and Cationic Liposomes Visualized by Freeze-fracture Electron Microscopy. FEBS Lett. 1994; 356: 361–366
- Ledley F.D. Nonviral Gene Therapy: The Promise of Genes as Pharmaceutical Products. Human Gene Ther. 1995; 6: 1129–1144
- Nahde T., Muller K., Fahr A., Muller R., Brusselbach S. Combined Transductional and Transcriptional Targeting of Melanoma Cells by Artificial Virus-like Particles. J. Gene. Med. 2001; 3: 353–361
- Pasqualini R., Koivunen E. Ruoslathi Symbol.av Integrins as Receptors for Tumor Targeting by Circulating Ligands. Nature Biotech. 1997; 15: 542–546
- Nettelbeck D.M., Jerome V., Muller R. Gene Therapy: Designer Promoters for Tumour Targeting. Trends Genet. 2000; 16: 174–181
- Fahr A., Welz C. Spectroscopic Methods for Characterisation of Nonviral Gene Delivery Systems from a Pharmaceutical Point of View. Appl. Spectr. Rev., In press
- Jaffe E. Culture and Identification of Large Vessel Endothelial Cells. Biology of Endothelial Cells, E. Jaffe. Martinus Nijhoff, Boston 1986; 1–13
- Thornton S.C., Mueller S.N., Levine E.M. Human Endothelial Cells: Use of Heparin in Cloning and Long-Term Serial Cultivation. Science 1983; 222: 623–625
- Chander R., Schreier H. Artificial Viral Envelopes Containing Recombinant Human Immunodeficiency Virus (HIV) gp160. Life Sci. 1992; 50: 481–489
- Weissig V., Lasch J., Klibanov A.L., Torchilin V.P. A New Hydrophobic Anchor for the Attachment of Proteins to Liposomal Membranes. Febs Letters 1986; 202: 86–90
- Kanda T., Sullivan K.F., Wahl G.M. Histone-GFP Fusion Protein Enables Sensitive Analysis of Chromosome Dynamics in Living Mammalian Cells. Curr. Biol. 1998; 8: 377–385
- Boehm T., Folkman J., Browder T, O'Reilly M.S. Antiangiogenic Therapy of Experimental Cancer Does not Induce Acquired Drug Resistance. Nature 1997; 390: 404–407
- Arap W., Pasqualini R., Ruoslahti E. Chemotherapy Targeted to Tumor Vasculature. Curr. Opin. Oncol. 1998; 10: 560–565
- Bentley N.J., Eisen T., Goding C.R. Melanocyte-Specific Expression of the Human Tyrosinase Promoter: Activation by the Microphthalmia Gene Product and Role of the Initiator. Mol. Cell. Biol. 1994; 14: 7996–8006
- Müller K. Entwicklung und Charakterisierung Eines Liposomalen Hybridvektors zur Antiangiogenen Gentherapie Von Tumorerkrankungen. PhD-thesis. Institute of Pharmaceutical Technology and Biopharmacy. Philipps-University Marburg, Marburg 2000
- Müller K., Nahde T., Fahr A., Müller R., Brüsselbach S. Highly Efficient Transduction of Endothelial Cells by Targeted Artificial Virus-Like Particles. Cancer Gene Therapy 2001; 8: 107–117